Malcolm A. S. Moore
Malcolm A. S. Moore | |
|---|---|
| Born | 18 January 1944 |
| Died | 23 September 2025 (aged 81) |
| Alma mater | Oxford University |
| Awards | William B. Coley Award (1995) |
| Scientific career | |
| Fields | Oncology, hematology |
| Institutions | Memorial Sloan-Kettering Cancer Center |
Malcolm A. S. Moore (18 January 1944 – 23 September 2025)[1] was a British-American biologist who served as the Enid A. Haupt Chair of Cell Biology at the Memorial Sloan-Kettering Cancer Center. Moore was an oncologist and hematologist known for the purification of human Granulocyte colony-stimulating factor and for being the principal investigator in the development of Filgrastim.[2] He was a member of various national and international societies and joined the editorial boards of a number of journals. He served or chaired committees of governmental and professional organizations, such as the Cancer Research Institute.[3]
References
- ^ Welte, Karl; Mertelsmann, Roland (December 2025). "In memoriam: Malcom A.S. Moore (1944–2025)". Leukemia. 39 (12): 3058–3058. doi:10.1038/s41375-025-02806-0.
- ^ Welte, K; Platzer, E; Lu, L; Gabrilove, J L; Levi, E; Mertelsmann, R; Moore, M A (March 1985). "Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor". Proceedings of the National Academy of Sciences. 82 (5): 1526–1530. doi:10.1073/pnas.82.5.1526. PMC 397296.
- ^ Staff, C. R. I. (10 October 2025). "Remembering Dr. Malcolm A.S. Moore, A Visionary Who Helped Change the Course of Cancer Treatment". Cancer Research Institute.